Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. IO Biotech ( (IOBT)) has shared an ...
The groundbreaking immunology research behind two Nobel Prizes awarded this week traces back to a largely forgotten biotech ...
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...
From regulatory reforms to rewarding research and discoveries instead of patients treated, the existing ecosystem needs many changes to be future-ready Every headline about Donald Trump’s tariffs ...
Rome Therapeutics is on the ropes, with the preclinical biotech planning layoffs for the end of the month, evaluating strategic options and ditching its physical headquarters to go entirely virtual, a ...
When it comes to Cyclerion Therapeutics' colorful backstory, the only consistency has been its inconsistency. Once upon a time, the Cambridge, Massachusetts-based company positioned itself as a ...
Oct 1 (Reuters) - Biotechnology firm Galapagos' (GLPG.AS), opens new tab board has received non-binding offers from several groups, mainly comprised of financial investors, for its cell therapy ...
TXSE plans to open doors in 2026 and begin vying for new listings Dallas-based exchange hopes to reverse trend of diminishing ranks of public companies TXSE backers include BlackRock, Citadel ...
(MENAFN- GlobeNewsWire - Nasdaq) SOUTH SAN FRANCISCO, Calif., Sept. 29, 2025 (GLOBE NEWSWIRE) -- Septerna, Inc. (NASDAQ: SEPN), a clinical-stage biotechnology company pioneering a new era of G protein ...